Journal for ImmunoTherapy of Cancer (Nov 2023)
160 Circulating tumor DNA for measurable residual disease (MRD) detection in multiple myeloma patients undergoing CAR T-cell therapy
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)